Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Linch

Showing results (91-100 of 129) with videos related to

Pageof 13
Sort By:
British Journal of Haematology|March 19, 2013
Improved intensive care unit survival for critically ill allogeneic haematopoietic stem cell transplant recipients following reduced intensity conditioningWilliam M Townsend, Ailsa Holroyd, Rachel Pearce, et al.
Blood|August 18, 2005
Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemiaRosemary E Gale, Robert Hills, Arnold R Pizzey, et al.
Nature Reviews. Disease Primers|May 10, 2016
Acute myeloid leukaemiaAsim Khwaja, Magnus Bjorkholm, Rosemary E Gale, et al.
Haematologica|March 10, 2018
Prognostic impact of the absence of biallelic deletion at the <i>TRG</i> locus for pediatric patients with T-cell acute lymphoblastic leukemia treated on the Medical Research Council UK Acute Lymphoblastic Leukemia 2003 trialNadine Farah, Amy A Kirkwood, Sunniyat Rahman, et al.
Blood|April 8, 2010
HLA-mismatched unrelated donors are a viable alternate graft source for allogeneic transplantation following alemtuzumab-based reduced-intensity conditioningAdam J Mead, Kirsty J Thomson, Emma C Morris, et al.
Ejhaem|July 18, 2022
Favourable outcomes for high-risk Burkitt lymphoma patients (IPI 3-5) treated with rituximab plus CODOX-M/IVAC: Results of a phase 2 UK NCRI trialElizabeth H Phillips, Catherine Burton, Amy A Kirkwood, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2010
T-cell-depleted reduced-intensity transplantation followed by donor leukocyte infusions to promote graft-versus-lymphoma activity results in excellent long-term survival in patients with multiply relapsed follicular lymphomaKirsty J Thomson, Emma C Morris, Don Milligan, et al.
Blood|December 8, 2009
The impact on outcome of the addition of all-trans retinoic acid to intensive chemotherapy in younger patients with nonacute promyelocytic acute myeloid leukemia: overall results and results in genotypic subgroups defined by mutations in NPM1, FLT3, and CEBPAAlan K Burnett, Robert K Hills, Claire Green, et al.
Blood|June 29, 2006
Two novel activating mutations in the Wiskott-Aldrich syndrome protein result in congenital neutropeniaPhil J Ancliff, Michael P Blundell, Giles O Cory, et al.
Lancet (London, England)|June 7, 2005
Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantationKarl S Peggs, Ann Hunter, Rajesh Chopra, et al.
Pageof 13

Showing results (91-100 of 129) with videos related to

Sort By:
Pageof 13
British Journal of Haematology|March 19, 2013
Improved intensive care unit survival for critically ill allogeneic haematopoietic stem cell transplant recipients following reduced intensity conditioningWilliam M Townsend, Ailsa Holroyd, Rachel Pearce, et al.
Blood|August 18, 2005
Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemiaRosemary E Gale, Robert Hills, Arnold R Pizzey, et al.
Nature Reviews. Disease Primers|May 10, 2016
Acute myeloid leukaemiaAsim Khwaja, Magnus Bjorkholm, Rosemary E Gale, et al.
Haematologica|March 10, 2018
Prognostic impact of the absence of biallelic deletion at the <i>TRG</i> locus for pediatric patients with T-cell acute lymphoblastic leukemia treated on the Medical Research Council UK Acute Lymphoblastic Leukemia 2003 trialNadine Farah, Amy A Kirkwood, Sunniyat Rahman, et al.
Blood|April 8, 2010
HLA-mismatched unrelated donors are a viable alternate graft source for allogeneic transplantation following alemtuzumab-based reduced-intensity conditioningAdam J Mead, Kirsty J Thomson, Emma C Morris, et al.
Ejhaem|July 18, 2022
Favourable outcomes for high-risk Burkitt lymphoma patients (IPI 3-5) treated with rituximab plus CODOX-M/IVAC: Results of a phase 2 UK NCRI trialElizabeth H Phillips, Catherine Burton, Amy A Kirkwood, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2010
T-cell-depleted reduced-intensity transplantation followed by donor leukocyte infusions to promote graft-versus-lymphoma activity results in excellent long-term survival in patients with multiply relapsed follicular lymphomaKirsty J Thomson, Emma C Morris, Don Milligan, et al.
Blood|December 8, 2009
The impact on outcome of the addition of all-trans retinoic acid to intensive chemotherapy in younger patients with nonacute promyelocytic acute myeloid leukemia: overall results and results in genotypic subgroups defined by mutations in NPM1, FLT3, and CEBPAAlan K Burnett, Robert K Hills, Claire Green, et al.
Blood|June 29, 2006
Two novel activating mutations in the Wiskott-Aldrich syndrome protein result in congenital neutropeniaPhil J Ancliff, Michael P Blundell, Giles O Cory, et al.
Lancet (London, England)|June 7, 2005
Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantationKarl S Peggs, Ann Hunter, Rajesh Chopra, et al.
Pageof 13